Skye Bioscience grants piggyback registration rights to Emerald Health for up to 16.6M warrant shares

Skye Bioscience, Inc.

Agreement dated Dec 14, 2022 with Emerald Health Sciences for piggyback rights on shares underlying warrants.
Warrants cover 16,641,486 shares in four tranches expiring Nov 2023 through Dec 2024.
Rights apply if Skye files a registration statement for a public offering; notice at least 30 days prior.
Underwriting may limit shares included; excluded shares are withdrawn from registration.
Company bears registration expenses up to $10,000 for EHS's legal fees; indemnification provisions included.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Skye Bioscience, Inc. entered into Registration Rights Agreement with Emerald Health Sciences, Inc. (effective 2022-12-14).

Action: entry
Counterparty: Emerald Health Sciences, Inc.
Effective: 2022-12-14

Exact text from the filing

On December 14, 2022, Skye Bioscience, Inc. (the "Company") and Emerald Health Sciences, Inc. ("Sciences") entered into a piggyback registration rights agreement (the "Registration Rights Agreement") pursuant to which, among other things, the Company has agreed to provide registration rights for the shares of common stock underlying the warrants to purchase Company common stock held by Sciences should the Company file a registr ation statement with the SEC for the purpose of effecting a public offering of common stock.

View on SEC.gov

Browse all material agreements →

Skye Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001516551-22-000054

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.